Coronary Arterial Smooth Muscle Contraction by a Substance Released from Platelets: Evidence That It Is Thromboxane A 2
- 17 September 1976
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 193 (4258), 1135-1137
- https://doi.org/10.1126/science.959827
Abstract
When human platelets are aggregated by thrombin, material is released that rapidly contracts strips of spirally cut porcine coronary artery. Prevention of the contraction by indomethacin suggested mediation by a prostaglandin. The contraction produced by aggregating platelets was unlike those produced by prostaglandins E2, F2alpha, G2, or H2, but resembled that evoked by thromboxane A2, which is formed by platelets during aggregation.Keywords
This publication has 9 references indexed in Scilit:
- Identification and assay of tetranor-prostaglandin E1 in human urineAnalytical Biochemistry, 1976
- Coronary Artery Spasm as a Cause of Acute Myocardial Ischemia in ManChest, 1975
- Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.Proceedings of the National Academy of Sciences of the United States of America, 1975
- Coronary Arterial Spasm in Classic Angina PectorisCatheterization and Cardiovascular Diagnosis, 1974
- An endoperoxide aggregator (LASS), formed in platelets in response to thrombotic stimuli-purification, identification and unique biological significanceProstaglandins, 1974
- Prostaglandin Endoperoxides. Novel Transformations of Arachidonic Acid in Human PlateletsProceedings of the National Academy of Sciences of the United States of America, 1974
- Isolation and Structure of Two Prostaglandin Endoperoxides That Cause Platelet AggregationProceedings of the National Academy of Sciences of the United States of America, 1974
- Coronary Arterial Spasm in Prinzmetal AnginaNew England Journal of Medicine, 1973
- Release of Additional Factors in Anaphylaxis and its Antagonism by Anti-inflammatory DrugsNature, 1969